Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Illumina    ILMN

ILLUMINA (ILMN)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/13/2018 02/14/2018 02/15/2018 02/16/2018 02/20/2018 Date
220.44(c) 223.11(c) 229.13(c) 229.2(c) 226.57(c) Last
663 027 817 930 804 863 701 696 567 764 Volume
-0.27% +1.21% +2.70% +0.03% -1.15% Change
More quotes
Financials ($)
Sales 2018 3 136 M
EBIT 2018 821 M
Net income 2018 628 M
Finance 2018 1 143 M
Yield 2018 -
Sales 2019 3 495 M
EBIT 2019 958 M
Net income 2019 732 M
Finance 2019 1 682 M
Yield 2019 -
P/E ratio 2018 53,83
P/E ratio 2019 46,27
EV / Sales2018 10,4x
EV / Sales2019 9,16x
Capitalization 33 692 M
More Financials
Company
Illumina, Inc. engages in the development and manufacture of integrated systems for the analysis of genetic variation and function.It operates through the Core Illumina and Consolidated Variable Interest Entity segments (VIE).The Core Illumina segment serve customers in the research, clinical and... 
More about the company
Surperformance© ratings of Illumina
Trading Rating : Investor Rating :
More Ratings
Latest news on ILLUMINA
02/14ILLUMINA : Launches Compact Next-Generation Sequencing System
AQ
02/13ILLUMINA : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
02/13LIFE SCIENCE REAGENT MARKET VALUE SH : Life Science Reagent Market Overview & In..
AQ
02/12ILLUMINA : Notice of Intent- Illumina, Inc.
AQ
02/08STUDIES FROM ILLUMINA HAVE PROVIDED : calling de novo copy number variants in p..
AQ
02/08ILLUMINA : Awarded $26.7M in Patent Suit Against Ariosa Diagnostics, Inc.
AQ
02/08ILLUMINA : Patent Issued for Selective Enrichment of Nucleic Acids (USPTO 987931..
AQ
02/08ILLUMINA : Free Post Earnings Research Report: Illumina’s Quarterly Revenue Surg..
AC
01/30ILLUMINA : beats Street 4Q forecasts
AQ
01/30ILLUMINA INC : Results of Operations and Financial Condition, Financial Statemen..
AQ
More news
Sector news : Advanced Medical Equipment & Technology - NEC
02/19Siemens Healthineers on track for March IPO
RE
02/08ATHENAHEALTH : Former GE CEO Jeff Immelt Named Chairman of Athenahealth -- Updat..
DJ
02/07GENERAL ELECTRIC : Former GE CEO Jeff Immelt Named Chairman of Athenahealth
DJ
02/03ROYAL PHILIPS : Investors Seek Answers on Health Fund -- WSJ
DJ
02/02ROYAL PHILIPS : Abraaj Investors Hire Auditor to Trace Money
DJ
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on ILLUMINA 
ILLUMINA - 02/16
The trend should regain control
BUY
ILLUMINA - 2017
There is still some upside potential
BUY
More Strategies
Latest Tweets
12:25pKBC Group NV Sells 4,250 Shares of Illumina, Inc. $ILMN  
02/19Why this big #biotech player is leaving #MissionBay for the Peninsula  
02/19Illumina, Inc. $ILMN Shares Bought by Virtu Financial LLC  
02/19Shell Asset Management Co. Decreases Holdings in Illumina, Inc. $ILMN  
02/18Illumina, Inc. $ILMN Shares Bought by State of Wisconsin Investment Board  
More tweets
Qtime:83
News from SeekingAlpha
02/08Battered Back Below $3, PacBio's Shares Offer High-Risk Upside 
02/05Premarket analyst action - healthcare 
02/01RiverPark Large Growth Fund Q4 2017 Performance Summary 
01/31Premarket analyst action - healthcare 
01/31WALL STREET BREAKFAST : Janet Yellen's Final Policy Meeting 
Chart ILLUMINA
Duration : Period :
Illumina Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Technical analysis trends ILLUMINA
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 258 $
Spread / Average Target 12%
EPS Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Ostadan Omead Executive Vice President-Products & Operations
Sam A. Samad Chief Financial Officer & Senior Vice President
Mostafa Ronaghi Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA2.11%33 692
THERMO FISHER SCIENTIFIC9.71%84 454
DANAHER3.53%67 849
INTUITIVE SURGICAL12.32%46 714
BOSTON SCIENTIFIC CORPORATION8.15%37 351
ROYAL PHILIPS-1.49%36 131